Wednesday, April 8, 2020
"Pandemic upends pot legalization: Ballot campaigns and cannabis bills get pushed aside during public health crisis"
The title of this post is the headline of this notable new Politico article, and here are excerpts:
What was supposed to be a banner year for marijuana legalization is becoming a bust.
Advocates are pushing ballot referendums in nearly a dozen states, from Idaho to New Jersey. Governors and state lawmakers who failed to pass legalization last year — most notably in New York — vowed that 2020 would be different. But social distancing has put ballot drives on pause and state lawmakers are overwhelmed with addressing the crisis at hand.
“People are scared. They don’t want to touch a pen or paper,” said Melissa Fults, executive director of Arkansans for Cannabis Reform. “All we can do is sit and wait.”
So even with marijuana sales spiking, the coronavirus pandemic is crippling marijuana legalization efforts on the state level — and campaigns on all kinds of other issues, too. “The coronavirus has impacted every signature drive on every issue across the country,” said Matthew Schweich, deputy director of legalization advocacy group Marijuana Policy Project.
Even New York Gov. Andrew Cuomo, who declared that marijuana legalization would be a “top priority” earlier this year, abandoned the initiative when his state emerged as the epicenter of the coronavirus outbreak in the U.S. “Too much [to deal with], too little time,” Cuomo said when asked about marijuana legalization during a recent press briefing.
A few states are poised to vote on marijuana referendums: New Jersey voters will decide whether to allow recreational marijuana sales in November, and Mississippians are expected to face two competing medical marijuana referendums.
But some ballot campaigns have abandoned this year’s plans and are eyeing 2022, and advocates are unsure what will happen to legalization bills with dozens of legislative sessions suspended or postponed. Even anti-legalization advocates are not cheering these developments. “Obviously this isn’t the reason we would want legalization measures to be set back,” said Kevin Sabet, president of Smart Approaches to Marijuana. “Lives are on the line.”
Nearly a dozen marijuana legalization ballot campaigns were angling for a spot on the 2020 ballot until coronavirus-related orders made it nearly impossible for canvassers to collect signatures. "[Circulating petitions] contributes to the public health problem," said Schweich. "There’s no playbook on how to do a signature drive during a pandemic."
Of all the legalization ballot campaigns still collecting signatures, Smart and Safe Arizona is perhaps the best positioned to succeed. It filed early and collected more than 300,000 signatures to date, well beyond the 238,000 verified signatures it needs by July 2 to qualify. Ballot campaigns typically submit more than the required number of signatures since a good portion generally can’t be verified by government officials. “Marijuana is in very good shape even with the lockdown order. We’d like to collect more,” said Stacy Pearson, a spokesperson for the campaign.
For other campaigns facing July deadlines, including Arkansas and Nebraska, advocates hope to get back out in the field in May. “[We] had already started hiring canvassers when this whole coronavirus thing happened,” said Tommy Garrett, a former Republican state senator in Nebraska who now serves as chairman of ADOPT, a statewide coalition that aims to reduce state property taxes and legalize medical marijuana....
The Arizona campaign recently joined three other ballot initiatives in filing a petition to the Arizona Supreme Court to allow them to use e-signatures. Advocates are looking into whether they can email people to find out if they are willing to sign a petition if it were dropped off outside their front door so they could use their own pens to sign it. The person could then leave the signed petition outside their door to be collected.
Arkansans for Cannabis Reform plans to work with two other campaigns on separate issues to help each other. The idea is to have canvassers for each campaign carry the petitions for all three signature drives. They’re discussing ways to safely collect signatures, such as having people drive up to canvassers to sign a petition while remaining in their cars. “We’re just going to have to get really creative,” Fults said.
Meanwhile, other recreational legalization campaigns are all but dead, including those in Missouri and Oklahoma. Medical marijuana legalization campaigns in Idaho and North Dakota have both expressed plans to focus their efforts on making the 2022 ballot instead.
"Coronavirus is taking up all the oxygen in the room," said Andrew Freedman, senior vice president at the public affairs firm Forbes Tate Partners. "People are just going to go home when all the essential business is passed." States with marijuana bills including Vermont, New Hampshire, New York and Connecticut all shifted their priorities as coronavirus cases surged....
Some advocates are hoping the crisis bodes well for legalization efforts in the long run, as states face revenue decimated by the crisis. "[Cannabis businesses] are taxed heavily,” said Richard Acosta, CEO of Subversive Real Estate Acquisition REIT, a cannabis-focused real estate investment operation. “The economic slowdown makes cannabis legalization at the state and federal level more attractive.”
Oklahoma Republican state Rep. Scott Fetgatter recently said he plans to introduce legislation to establish a taxed, regulated recreational marijuana market, arguing it could bring in $100 million per year in revenue and help with a budget crunch expected because of the health crisis.
But until the worst is over, lawmakers likely will be consumed with more urgent matters. Legislative leaders in Connecticut, who had been discussing marijuana legalization matters with Democrat Gov. Ned Lamont, are now working with the governor on a coronavirus stimulus package. The session has been postponed until at least April 13.
A medical marijuana legalization bill was chugging along in Kentucky’s legislature with a 65-30 vote in the Republican-dominated House. Now, the bill is languishing in the Senate Judiciary Committee as the legislature swerved to deal with the state budget amid the coronavirus crisis.
Some prior COVID-cannabis related posts:
- Drug Enforcement and Policy Center conducting new survey on COVID-19 impacts on cannabis industry
- "Coronavirus Upends Marijuana, Psychedelics And Drug Reform Ballot Measures"
- Just some of the latest headlines highlighting how COVID-19 is changing the marijuana reform world
- "Cannabis finds its moment amid coronavirus outbreak"
- Advocacy groups urge ceasing of cannabis arrests and release of cannabis offenders during COVID-19 outbreak
- Advocacy groups urge governors to ensure "medical cannabis patients do not experience disrupted access to crucial medicine" during COVID crisis
- In a post-COVID economy, will job creation and tax revenue from marijuana reform become irresistible?
April 8, 2020 in Campaigns, elections and public officials concerning reforms, Who decides | Permalink | Comments (0)
Tuesday, March 31, 2020
The title of this post is the headline of this new Forbes piece by Tom Angell highlighting one way that the COVID-19 crisis seems certain to slow the drug law reform momentum heading into November. Here are the details:
Marijuana and drug policy reform advocates came into 2020 believing it would be a big — and perhaps unprecedented — year for legalization and decriminalization measures on state ballots. From California to Missouri to Oregon, they had high hopes for placing far-reaching initiatives before voters in November.
But many of those efforts have been severely impeded by the coronavirus pandemic, which has made mass signature gathering to qualify ballot measures all but impossible as public health and government officials have urged social distancing measures.
Here’s a look at the growing list of ballot initiatives on cannabis and broader drug reforms that have been effectively halted by the COVID-19 outbreak.
Separate campaigns to amend California’s legal marijuana program and legalize psilocybin mushrooms are calling on officials to allow them to collect ballot signatures digitally instead of in-person due to the health risks of the the latter traditional route amid the pandemic. So far those requests seem to have been ignored.
Activists in Missouri announced that they have “no practical way” of collecting enough signatures to place a marijuana legalization measure before voters amid the pandemic and are now considering shifting their focus to the 2022 election.
A campaign working to qualify a medical cannabis measure for the November ballot is temporarily suspending signature gathering efforts during the coronavirus outbreak “out of an abundance of caution.”
Activists behind a measure to decriminalize possession of all drugs and expand treatment services using current marijuana tax revenue has halted in-person signature collection efforts. That said, the campaign says it has almost enough to qualify and so is urging supporters to download, print, sign and mail petitions to help. Also in Oregon, a separate team of advocates working to legalize the therapeutic use of psilocybin mushrooms has also suspended mass signature collection efforts despite similarly having almost enough to ensure ballot access. They are asking people who want to sign to fill out an online form so that petitions can be mailed to them.
Activists in the nation’s capital were hoping to give voters a chance to decide on a measure to effectively decriminalize a wide range of psychedelics—including psilocybin, ayahuasca and ibogaine — in November. But they, like their colleagues in states across the country, have acknowledged that the COVID-19 pandemic makes in-person signature collection virtually impossible. They’ve asked for a change in the law to allow for electronic petition signing, but officials have demurred, and so the campaign is now exploring a plan to mail petitions to supporters who would then collect signatures from their immediate family members and close friends.
Beyond the ballot, the coronavirus outbreak has also impeded efforts to advance marijuana reform bills through state legislatures in place like Connecticut, New York and Vermont as sessions have been largely halted due to health concerns.
But ... in South Dakota, separate measures to legalize marijuana and allow medical cannabis have already qualified for the state’s November ballot.... In Mississippi, the state certified that advocates collected a sufficient number of signatures to place a medical marijuana legalization question before voters.... In New Jersey, the legislature voted late last year to place a marijuana legalization referendum on the November ballot. And in Arizona, activists announced last week that they have already collected more signatures than needed to qualify a marijuana legalization measure for the ballot — though they have not yet been submitted to and verified by the state.
This accounting leave out Ohio, where a campaign for full legalization of marijuana was just getting launched when COVID-19 started shutting down the state. I suspect still other states and localities may have had similar nascent efforts shut down as well.
Friday, March 27, 2020
Advocacy groups urge ceasing of cannabis arrests and release of cannabis offenders during COVID-19 outbreak
As detailed in this press release, the "Last Prisoner Project and other organizations are urging law enforcement officials to dramatically curtail arrests for non-violent crimes, including ceasing arrests for cannabis offenses. In addition to curtailing arrests, the organizations are calling for officials to release or grant clemency to those incarcerated for cannabis offenses along with dramatically reducing the number of incarcerated non-violent prisoners, whether sentenced or un-sentenced." Here is more:
The Marijuana Policy Project, Last Prisoner Project, Law Enforcement Action Partnership, Clergy for a New Drug Policy, Doctors for Cannabis Regulation, National Cannabis Industry Association, Students for Sensible Drug Policy, and National Organization for the Reform of Marijuana Laws (NORML) have sent a letter calling for these actions to the National District Attorneys Association, National Governors Association, National Sheriffs’ Association, National Association of Chiefs of Police, National Correctional Industries Association, American Correctional Association, and AFSCME.
The letter is available at this link, and here are excerpts:
[W]e are imploring you to curtail arrests for non-violent offenses, such as marijuana possession, cultivation, and sale until the country is better able to prevent the spread of the coronavirus. Similar actions have already been taken in Pennsylvania, Ohio, and nationally by U.S. Immigrations and Customs Enforcement.
Many jurisdictions give police broad discretion to choose infractions and summonsed misdemeanors as alternatives to serious charges and arrests. In addition, officers have wide discretion to merely provide warnings for minor offenses. We encourage broad use of this flexibility in the face of the COVID-19 outbreak.
In addition to curtailing arrests, we are urging you to release cannabis offenders, along with dramatically reducing the number of incarcerated non-violent prisoners, whether sentenced or un-sentenced. By significantly reducing the number of inmates in local jails and prisons, you can ultimately reduce the risk of the coronavirus being spread amongst inmates, staff, and the community. Guards return to their families and communities after their shifts, as do prisoners upon their release. The larger the number of individuals incarcerated, the greater the likelihood and possible scope of a related outbreak. This puts prisoners, guards, and the larger community at risk as the communities grapple with this public health crisis. Significantly reducing the number of inmates is a necessary step to ensuring public health in the face of this crisis.
Many localities — including Baltimore; Suffolk County, Massachusetts; Cuyahoga County, Ohio; New Jersey; Los Angeles; and New York City — and the Federal Bureau of Prisons have already begun to release inmates incarcerated for non-violent, drug-related offenses with the understanding that infections in prisons and jails are rampant, and releasing inmates could save the lives of not only inmates but also the custodial, medical, and safety staff that serve them.
The title of this post is the title of this notable new Politico piece. Here are excerpts:
Cannabis is turning out to be the one thing the coronavirus can’t destroy.
Marijuana sales are booming, with some states seeing 20 percent spikes in sales as anxious Americans prepare to be hunkered down in their homes potentially for months. Weed sellers are staffing up too, hiring laid-off workers from other industries to meet demand. And in the midst of a historic market meltdown, stock prices for cannabis companies have surged, in some cases doubling since the public health crisis began.
“We are hiring because we are having to shift our business a bit,” said Kim Rivers, CEO of Trulieve, which is valued at $1 billion. The company is staffing up its delivery fleet, retail workers, and people to handle increased inventory shipments. “Now is a great time [to apply], particularly if you’re in a business that has seen layoffs.”
Nearly all of the 33 states with legal medical or recreational markets have classified marijuana businesses as an essential service, allowing them to remain open even as vast swaths of the retail economy are shuttered. San Francisco and Denver initially announced plans to shut down dispensaries, but immediately backpedaled after a public furor.
Weed shops are essentially being treated the same as pharmacies, reflecting a dramatic shift in cultural perceptions about the drug over the last decade. “It is a recognition that it has taken on much greater significance around the country,” said Rep. Earl Blumenauer (D-Ore.), a longtime Capitol Hill champion for cannabis. “This is something that makes a huge difference to the lives of hundreds of thousands of people every day. I do think that this might be part of a turning point.“
Concerns about whether smoking pot is the smartest response to a pandemic that’s causing severe lung injuries in tens of thousands of Americans have been largely drowned out. "Public opinion has pushed lawmakers to think about cannabis — and particularly medical cannabis — in different ways than they used to," said John Hudak, a cannabis policy expert at the Brookings Institution, and author of Marijuana: A Short History. "A lot of state policymakers are trying to get this right and they obviously see the risk of shutting down a dispensary to be higher than the rewards of shutting down a dispensary."...
The burgeoning industry does face some stiff financial headwinds: The massive stimulus package moving through Congress this week to help beleaguered businesses shuts out cannabis companies from taking advantage of its benefits, reflecting the continued federal illegality of marijuana. Prior to the recent boom in sales, the industry had been in financial turmoil, with many companies laying off workers and scuttling acquisitions as they ran short on cash. “I'm frustrated Senate Republicans refused to allow us to include them in this legislation, but we aren't giving up," Sen. Patty Murray (D-Wash.) said Wednesday.
In addition, some medical experts question the wisdom of allowing uninhibited access to marijuana during a massive public health crisis. They worry that customers flocking to pot shops could spread the virus, that stoned customers will engage in risky behavior and that smoking pot will worsen the lung damage for people who do become infected. “If you keep the pot stores open, you're just adding fuel to the fire,” said Karen Randall, an emergency room doctor in Colorado. “You're having a whole bunch of people who are trashing their lungs.”...
The federal government said Thursday that a staggering 3.3 million people applied for unemployment benefits last week. While the cannabis industry can’t do much to remedy that bloodletting, some companies are looking to hire people who have recently lost their jobs. Harborside — which operates three shops in the Bay Area — found itself suddenly understaffed as delivery requests increased by 45 percent and phone calls exploded from around 100 to 8,000 per day.... Harborside has hired 10 employees in the last few weeks — some of whom were directly laid off as a result of the coronavirus — and plans to hire at least six more. The largest increase was in their delivery fleet, going from four drivers to 10.
And they’re not alone. “Two and a half weeks ago, our sales just exploded,” said Zachary Pitts, CEO of California cannabis delivery service Ganja Goddess. “People are leaning on delivery more now … even though storefronts are still open in California.” Pitts estimated that he’s increased his workforce by about 15 percent in recent weeks, and is working on hiring more. The company has suspended normal vetting processes and is instead relying on trusted referrals....
As states move to declare marijuana an essential business, the gulf between state and federal policy has never been wider. Congress is poised to enact a $2 trillion stimulus package this week, but the cannabis industry will not see a cent. “In the same way that cocaine dealers in the United States who are suffering under Covid-19 are not going to be eligible for relief under the stimulus bill, cannabis companies won't either,” said Hudak of the Brookings Institution. “Illegal businesses do not access legal funding.”
The cannabis industry generated $15 billion in sales last year and employs 340,000 people. Employers and workers pay federal taxes, and are required to comply with other coronavirus-related measures such as paid sick leave coverage. But for cannabis companies to access assistance made available through the stimulus package, Congress or the administration would need to dictate their inclusion. A spokesperson for Sen. Jeff Merkley (D-Ore.) said he wants to include such a provision in a future coronavirus aid package. Similarly, Murray said she is “exploring what can be done in the upcoming appropriations process to help them through this crisis and beyond."
March 27, 2020 in Business laws and regulatory issues, Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Medical Marijuana Commentary and Debate, Political perspective on reforms, Recreational Marijuana Commentary and Debate | Permalink | Comments (0)
Wednesday, March 25, 2020
At Brookings, Makada Henry-Nickie and John Hudak have this interesting new brief as part of its "Policy 2020" series titled "It is time for a Cannabis Opportunity Agenda." Here is the paper's executive summary:
The 2020 election season will be a transformative time for cannabis policy in the United States, particularly as it relates to racial and social justice. Candidates for the White House and members of Congress have put forward ideas, policy proposals, and legislation that have changed the conversation around cannabis legalization. The present-day focus on cannabis reform highlights how the War on Drugs affected targeted communities and how reform could ameliorate some of those wrongs. The national conversation on cannabis stands at a pivotal inflection point that provides policymakers and legislators with an extraordinary opportunity to establish a policy context wherein inclusive economic opportunities can thrive in tandem with responsible investments to redress longstanding harms.
When Congress works to remedy a discriminatory past or to rectify decades of institutionalized bias, it has an obligation to thoroughly consider implicit and explicit hurdles to equity. Nowhere is this deliberation more critical than in drug policy reform. For decades, the criminalization of drugs led to foreclosed opportunities for people of color who were disproportionately victimized by unequal criminal enforcement. In 2013, police officers were 3.73 times more likely to arrest people of color for cannabis possession than whites. Arrest disparities were even more egregious in some communities where Blacks were 8.3 times more likely than whites to be arrested for possession. The racist roots of the War on Drugs inflicted significant collateral damage on minority groups, saddling young men and women of color with drug convictions — often before age 30 — and setting them on a course of institutionalized disadvantage because of the crippling, collateral consequences of criminal records.
Today, amidst a thriving state-legal cannabis industry, the same people hurt most by the drug war face the greatest barriers to participating in the emerging cannabis economy. As elected officials consider how to reform the nation’s cannabis laws and rectify these serious socioeconomic and racial issues, they must erase any ambiguity about the protections, corrective actions, and inclusive opportunities intended to reverse the generation-long ills of the War on Drugs. We argue that 2020 is an opportune moment to design a comprehensive pragmatic Cannabis Opportunity Agenda: a set of policies that addresses the social harms of marijuana prohibition and seeks to rehabilitate impacted communities with a focus on equity, opportunity, and inclusion.
March 25, 2020 in Campaigns, elections and public officials concerning reforms, Criminal justice developments and reforms, History of Marijuana Laws in the United States, Race, Gender and Class Issues, Recreational Marijuana Commentary and Debate | Permalink | Comments (0)
Advocacy groups urge governors to ensure "medical cannabis patients do not experience disrupted access to crucial medicine" during COVID crisis
I just saw that, earlier this week, an array of advocacy groups sent this short letter to the National Governors Association headed "Emergency Call To Action To Governors In States With Medical Cannabis Programs." Here is the heart of the letter (which also attaches a similar letter from last week from Americans for Safe Access):
In the midst of the COVID-19 pandemic, the undersigned national drug policy, HIV/AIDS, and public health organizations write to all U.S. governors and medical cannabis program directors to amplify a letter sent last week by the nation’s leading medical cannabis and patient advocacy group, Americans for Safe Access (ASA). We are joining their call for necessary, immediate actions and safeguards to ensure that medical cannabis patients do not experience disrupted access to crucial medicine.
Thirty-three states and the District of Columbia have medical cannabis laws enacted and, cumulatively, these states serve over three million patients. Medical cannabis patients often live with debilitating ailments, such as cancer, HIV/AIDS, and chronic pain that significantly affect quality of life. It is critical that policymakers and other decision makers who are working to address the current COVID-19 pandemic are also considering the public health consequences that will follow the decision to abruptly interrupt the legal supply chain for medical cannabis patients. We are especially worried about vulnerable patients being unintentionally pushed to the unregulated market, where there will not be access to lab-tested, tightly controlled products. This could endanger the health of those who rely on cannabis as medicine.
The undersigned organizations -- who support research and access to medical cannabis -- join ASA in calls for the recognition of medical cannabis as necessary medicine and for the recommendations below to be implemented to ensure that patients’ access to medicinal cannabis will continue.
Tuesday, March 3, 2020
As noted in this post, last week news broke that there was in the works a serious attempt to bring a full marijuana legalization initiative to Ohio voters in 2020. This local press piece, headlined "Ohio 2020 recreational marijuana legalization measure filed: 5 things to know," report on that effort and (some of) what we all need to know. Here are excerpts:
The latest effort to legalize marijuana in Ohio stems from frustration with Ohio's nearly four-year-old medical marijuana law. Supporters of the measure include at least two medical marijuana businesses, a medical marijuana patient, a mother of twins with autism – a condition excluded from the program – and advocates for recommending cannabis in place of opioids.
Supporters of the Regulate Marijuana Like Alcohol Amendment turned in the petition summary language and an initial 1,000 signatures to the Ohio attorney general on Monday. This is the first step in a months-long process to qualify for the November ballot. The constitutional amendment would allow adults over age 21 to buy, possess, consume and grow limited amounts of marijuana....
Tom Haren, a Northeast Ohio attorney representing supporters, said there were several catalysts in the medical program that led to the new adult use measure. "If you're a patient in Ohio, it's hard to participate in Ohio's medical marijuana program," said Haren, who has also represented medical marijuana licensees. "We were promised a program that worked." Haren confirmed Pure Ohio Wellness, a cultivator and dispensary operator in Springfield and Dayton, and Galenas, a small-scale grower in Akron, are backing the measure. Haren said other medical marijuana businesses support it but declined to name them on Monday.
The Ohio Medical Cannabis Industry Association, which represents 14 Ohio companies, is not supporting the measure. “We’re focused on the medical program and at this time are not backing a recreational initiative,” association associate director Thomas Rosenberger said.
The purchase and possession limit in the amendment is 1 ounce, with no more than 8 grams of concentrate. Adults could grow up to six plants (limit of three flowering plants) in an enclosed area – home grow is not allowed in the medical marijuana program. The state's nascent medical marijuana program would remain in place, and state officials would have to ensure patients still have access to products.
The amendment wouldn't change laws against driving under the influence of marijuana or employers' rights to prohibit employee marijuana use....
The 118 medical marijuana licensees could operate as recreational businesses on July 1, 2021, according to the amendment. The Ohio Department of Commerce, which oversees medical marijuana growers, processors and testing labs, would also regulate the entire recreational marijuana program.
The agency could issue more licenses, but the number of licenses would be capped until 2026. Retail stores would be capped at about 200. Cultivation would be limited to a total of 1.5 million square feet of growing space among all licensees. For comparison, the state's 19 large-scale and 13 small-scale medical marijuana growers are licensed to cultivate 514,000 square feet.
Local governments could limit the number, location and business hours of marijuana businesses and could ban them altogether. Licenses would be awarded if the applications comply with the rules and regulations; Ohio's medical marijuana business licenses were awarded after a months-long application scoring process....
The amendment doesn't set a tax rate – that would likely violate an anti-monopoly amendment passed by voters in 2015 to block ResponsibleOhio's recreational marijuana measure. Lawmakers could set a special sales tax for recreational marijuana.
Revenue from marijuana would be split several ways:
- 25% to a special fund for a Commission on Expungement, Criminal Justice, Community Investment, and Cannabis Industry Equity and Diversity
- 50% allocated to the state's Local Government Fund
- At least 10% must be returned to municipalities where retail sales occurred, proportional to the amount of sales
Equity in legal cannabis programs refers to ensuring African-Americans and members of other traditionally marginalized groups participate in the industry. African-Americans are nearly four times more likely than whites to be arrested for marijuana possession, according to the ACLU.
Ohio's attempt at equity in the medical marijuana program – awarding 15% of all licenses to minority-owned businesses – was found unconstitutional. The amendment requires the Department of Commerce to conduct a study into whether there has been discrimination in awarding medical marijuana licenses.
The attorney general has 10 days to review the petition language to make sure it's "fair and truthful" summary of the amendment. Most initiatives don't pass the first time. A bipartisan legislative panel led by the Ohio secretary of state will then decide whether the measure is one or more ballot issues. Then, supporters will have to have to collect at least 442,958 valid signatures of Ohio voters, including a certain percent in 44 of Ohio's 88 counties.
To do that before July 1 – the deadline for the November ballot – supporters will likely need to hire paid signature collectors. Recent statewide ballot issue campaigns have spent upwards of $3 million to collect signatures. Haren declined to name investors or sources funding the campaign. "We expect it will be funded by a diverse set of folks including people with licenses as well as folks outside the licensing," Haren said.
The full text of the the ballot initiative, titled "An Amendment to Regulate Marijuana Like Alcohol," is available at this link. Once I get a chance to read the text in full, I suspect I will have a lot more to say about how this proposal seek to make marijuana fully legal in the Buckeye State.
Wednesday, February 26, 2020
Throughout the first part of 2019, I thought it quite likely that there would be at least an attempt to bring a full marijuana legalization initiative to Ohio voters in 2020. But as 2019 marched forward and as I heard that some Ohio medical marijuana industry players were against such an effort, I concluded that the Buckeye voters were going to have to wait until at least 2022 to weigh in again on recreational marijuana. But, to my surprise, this news broke this week: "Ohio petitioners want to put recreational marijuana on the fall ballot." Here are the basics and some context:
Advocates of adult marijuana use, which includes some licensed Ohio medical marijuana companies, are working on letting citizens vote on recreational marijuana this fall.
But an initiative to bring a referendum before voters this November will face an uphill battle, as it may be challenging to collect the signatures needed by a July deadline to get a measure on this fall's ballot. Presidential elections historically draw the greatest voter turnouts, which is why it makes sense strategically to bring out a marijuana legalization referendum at that time despite the time crunch.
According to the Cincinnati Enquirer, which says it's seen a copy of the petitions, the proposed constitutional amendment would "allow anyone 21 and older to buy, consume and possess up to one ounce of marijuana and grow up to six marijuana plants." Additionally, the Enquirer reported that "Ohio's existing medical marijuana businesses would have first dibs on the recreational market beginning in July 2021. State regulators could decide to issue additional licenses."
Matt Close, executive director of the Ohio Medical Cannabis Industry Association, which includes about 15 members, said the trade group is aware of the petitions but is not backing any legalization measure, at least not yet. "From the association standpoint right now, we are not backing any sort of initiative," Close said. "We are trying to fix the current program."... Nonetheless, while it's currently unclear who's supporting the legalization initiative, sources say the group does include some current Ohio medical marijuana license-holders.
According to the Ohio attorney general's office, a statewide total of 442,958 signatures would be required from at least 44 of the state's 88 counties to file a ballot initiative. That number is particularly high because of the high voter turnout in the last gubernatorial election. Petitions can be tricky because a number of signatures will inevitably be marked invalid. Collecting nearly 443,000 valid signatures means petitioners would likely want to collect double the required number to be safe. If initial petitions are filed with the state later this week, the initiative would have just four months to collect signatures before the July 1 deadline. A successful campaign would probably take several million dollars of financial support.
The last marijuana referendum brought before voters was Issue 3 in 2015. While that would've established a recreational market, the amendment would've provided for only 10 cultivators chosen by backers of the bill, including '90s boy-band singer Nick Lachey of 98 Degrees. Critics, including the state, which worried about losing control of the marijuana situation, framed Issue 3 as a monopoly on the lucrative cultivation business. While not a literal monopoly, the idea was that one group of investors working together would effectively gain unilateral control over who would be allowed to grow medical pot and where in the Buckeye State. That left many marijuana advocates unimpressed.
H.B. 523 followed in 2016 as a way for lawmakers to create a strictly regulated medical marijuana industry after seeing a recreational industry nearly willed into existence. Former Gov. John Kasich eventually signed that bill to little fanfare. Medical marijuana sales in Ohio started in January 2019. The state saw $58.3 million in total sales in that first year, a good deal less than comparable markets in their inaugural years.
I am very much looking forward to seeing the details of the petition, which should be out this week or next, and also seeing of the organizers will have the resources to collect the signatures needed to actually get the petition to the ballot. Stay tuned.
Tuesday, February 25, 2020
I have to give a shout out to CBS News for asking a direct question on marijuana policy and reform, though only three candidates had time during the debate to speak to the issue. This live-time coverage of the debate reports on the (mostly unsurprising) comments from the candidates under the heading "Sanders pushes ahead on legalizing marijuana, but isn't joined by other candidates":
Klobuchar was given the first chance to address the issue of legalizing marijuana. "Well, it is realistic to want to legalize marijuana, I want to do that, too," Klobuchar said.
The Minnesota senator added there also needs to be funding for treatment, so there aren't "repeat customers."
Bloomberg said small amounts of marijuana possession shouldn't be criminalized. And legalization wouldn't be taken away from states that have already legalized the drug. But he admitted there isn't enough research on mairjuana to know how much damage marijuana does, particularly on young minds, so he isn't pushing for full legalization at this point. "Until we know the science, it's just nonsensical to push ahead," Bloomberg said.
Sanders blasted the "horrific war on drugs," and said he would "effectively legalize" marijuana. He also said he wants to move to expunge the records of people with marijuana convictions.
February 25, 2020 in Campaigns, elections and public officials concerning reforms, Criminal justice developments and reforms, Federal Marijuana Laws, Policies and Practices, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Tuesday, February 4, 2020
The question in the title of this post is the headline of this lengthy and effective new Marijuana Moment piece by Kyle Jaeger. I recommend the piece in full (especially to my students), and here is how it gets started:
Sen. Bernie Sanders (I-VT) is making a bold promise: if elected president, he will legalize marijuana in all 50 states on his first day in office. “We will end the destructive war on drugs,” the 2020 Democratic candidate said at rally days before this week’s Iowa caucus. “On my first day in office through executive order we will legalize marijuana in every state in this country.”
But while the pledge has been largely welcomed by reform advocates and cannabis enthusiasts, some experts question whether such immediate, sweeping action is legally or practically achievable.
The use of executive orders at the start of a presidency isn’t unprecedented — President Obama signed one aimed at shutting down the controversial Guantanamo Bay prison the day after he assumed office and President Trump issued an order scaling back Obamacare, for example — but there are unique challenges associated with a presidential move to unilaterally remove cannabis from the Controlled Substances Act (CSA).
To effectively end marijuana prohibition through the executive branch, according to an analysis from the Brookings Institution’s John Hudak, the secretary of the Department of Health and Human Services (HHS) or an outside party would have to file a petition, which would then be reviewed by the attorney general, who has usually delegated that responsibility to the Drug Enforcement Administration (DEA). The attorney general can also initiate the process on their own, requesting a scientific review directly to HHS. Under HHS, the Food and Drug Administration (FDA) would then assess the scientific, medical and public health implications before submitting that review to the Justice Department.
“The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance,” the CSA states. “If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal.”
Thus, changing marijuana’s classification under federal law without an act of Congress is far more complicated than a single stroke of a presidential pen. While Sanders could theoretically make supporting descheduling a condition of nominating candidates to be HHS secretary or attorney general, it’s virtually certain he would not have those officials installed on day one of his presidency.
The new day-one, executive action proposal is a far more ambitious plan than the one Sanders previously floated. Last year, the senator said he’d take a systematic approach to legalization that would involve naming cabinet members who will “work to aggressively end the drug war and legalize marijuana” within 100 days of his taking office.
But it appears the timetable has changed, with top aides reportedly including marijuana legalization in a list of possible executive orders — though Sanders has yet to formally sign off on them. Some experts are skeptical that this latest plan has legs, and some feel it reflects Sanders’s political desire to stand out as the most marijuana friendly candidate, rather than an earnest attempt to expedite the descheduling process.
Monday, February 3, 2020
NORML releases new scorecard of Governors based on "comments and voting records in 2019 specific to matters of marijuana policy"
Last week the acvocacy group NORML released here its "2020 Gubernatorial Scorecard" which constitutes an "extensive database assign[ing] a letter grade 'A' through 'F' to states' governors based upon their comments and voting records in 2019 specific to matters of marijuana policy." Here is part of the executive summary:
Public opinion in support of marijuana law reform, including adult-use legalization, is at an all-time high. Nonetheless, few federal lawmakers are espousing views on cannabis policy that comport with those of the majority of their constituents. As a result, most legislative activity specific to marijuana policy takes place at the state level. America's governors are our nation's most powerful state-elected officials and they often play a key role in this ongoing legislative debate. Here is where each of them stands on issues surrounding cannabis policy.
Thirty-two US governors received a passing grade of 'C' or higher (22 Democrats, 10 Republicans); last year, only 27 Governors received a grade of 'C' or higher.
Of these, nine US governors -- all Democrats -- received an 'A' grade.
Twelve governors received a 'B' grade (11 Democrats, 1 Republican)
Eleven governors received a 'C' grade (9 Republicans, 2 Democrats)
Ten governors -- nine Republicans and one Democrat -- received a 'D' grade
Eight governors -- all Republicans -- received a 'F' grade
Among Democratic Governors, 39 percent received an 'A.' Ninety-six percent of Democratic Governors received a grade of 'C' or higher.
Among Republican Governors, only 37 percent received a grade of a 'C' or higher. Thirty percent received a failing grade.
Political support among US governors for marijuana policy reform continues to grow. However, this support is more partisan than ever before. No Republicans are on record in support of adult-use legalization and few are in favor of regulating medical cannabis access. By contrast, a large percentage of Democrats are supportive of both issues. This partisan divide is not similarly reflected among the general public. According to national polling data compiled by Gallup in October 2019, 66 percent of the public -- including majorities of self-identified Democrats, Republicans, and Independents -- favor adult-use legalization. Bipartisan support among the public for medical marijuana legalization is even stronger. Until this public support is similarly reflected among lawmakers, many cannabis-specific legislative reforms – in particular adult-use legalization proposals – will continue to meet resistance at the state level.
February 3, 2020 in Campaigns, elections and public officials concerning reforms, Medical Marijuana State Laws and Reforms, Political perspective on reforms, Polling data and results, Recreational Marijuana State Laws and Reforms, Who decides | Permalink | Comments (0)
Monday, January 20, 2020
Taking stock of 2020 marijuana reform prospects in various states (and noting some significant omissions)
Jeff Smith over at MJBizDaily has this helpful article (with a helpful graphic) under the headline "Several states could legalize cannabis sales in 2020 as marijuana industry eyes lucrative East Coast market." The article maps out the ten or so states that might move forward with adult-use legalization regimes in 2020 and also reviews the handful of states in which medical marijuana legalization might move forward this year. Here is a snippet from the start of the piece:
Up to a dozen states could legalize adult-use or medical marijuana in 2020 through their legislatures or ballot measures, although only about a handful will likely do so.
Much of the cannabis industry’s focus will home in on a possible recreational marijuana domino effect along the East Coast, which could create billions of dollars in business opportunities. Adult-use legalization efforts in New York and New Jersey stalled in 2019, but optimism has rekindled this year.
Potential legalization activity runs from the Southwest to the Dakotas to the Deep South. Mississippi in particular has a business-friendly medical cannabis initiative that has qualified for the 2020 ballot.
If even a handful of these state marijuana reforms move forward this year, it becomes that much more likely that some form of federal reform will have to follow. That reality is one of the theme of this lengthy new Politico article which also provides an accounting of potential state reforms under the full headline "Marijuana legalization may hit 40 states. Now what?: Changes in state laws could usher in even more confusion for law enforcement and escalate the pressure on Congress to act." Here is an excerpt:
More than 40 U.S. states could allow some form of legal marijuana by the end of 2020, including deep red Mississippi and South Dakota — and they’re doing it with the help of some conservatives. State lawmakers are teeing up their bills as legislative sessions kick off around the country, and advocates pushing ballot measures are racing to collect and certify signatures to meet deadlines for getting their questions to voters.
Should they succeed, every state could have marijuana laws on the books that deviate from federal law, but people could still be prosecuted if they drive across state lines with their weed, because the total federal ban on marijuana isn’t expected to budge any time soon. The changes could usher in even more confusion for law enforcement and escalate the pressure on Congress to act. Federal bills are crawling through Congress, with Senate Majority Leader Mitch McConnell firmly against legalization....
“We’re cautiously optimistic that we can win more marijuana reform ballot initiatives on one Election Day than on any previous Election Day,” said Matthew Schweich, deputy director of the Marijuana Policy Project. Schweich cited growing public support for the issue among both liberals and conservatives. The measures that make the ballot could drive voter turnout at the polls and by extension affect the presidential election.
Liberal states that allow ballot petitions have largely voted to legalize marijuana, including California, Oregon and Massachusetts. “Now, we’re venturing into new, redder territory and what we’re finding is voters are ready to approve these laws in those states,” said Schweich, who, along with leading legalization campaigns in Maine, Massachusetts and Michigan, served as the co-director of the medical marijuana legalization campaign in Utah. “If we can pass medical marijuana in Utah, we can pass it anywhere.”
National organizations like his are eschewing swing states like Florida and Ohio, where the costs of running a ballot campaign are high during a presidential election. They are intentionally targeting states with smaller populations. For advocates, running successful campaigns in six less-populous states means potentially 12 more senators representing legal marijuana states. “The cost of an Ohio campaign could cover the costs of [four to six] other ballot initiative campaigns. Our first goal is to pass laws in as many places as we can,” Schweich said.
They can’t take anything for granted, however. In Florida, where polling says two-thirds of voters want to legalize pot, one effort to gather enough signatures for a 2020 ballot measure collapsed last year, and a second gave up on Tuesday, saying there’s not enough time to vet 700,000 signatures. Organizers are looking to 2022. And many legislative efforts to legalize marijuana came up short in 2019, including in New York and New Jersey. Those efforts were derailed in part over concerns about how to help people disproportionately harmed by criminal marijuana prosecutions, despite broad support from Democratic-controlled legislatures and the governors.
I fully understand the strategic and economic reasons why MPP and other national marijuana reform activist groups have chosen not to focus on big purple states like Florida and Ohio for full legalization campaigns. But these two states have unique long-standing and well-earned reputations as national swing states. Only if (when?) these kinds of big (reddish-purple) states go the route of full legalization will I think federal reform becomes unavoidable.
January 20, 2020 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, History of Marijuana Laws in the United States, Medical Marijuana State Laws and Reforms, Recreational Marijuana Commentary and Debate, Recreational Marijuana State Laws and Reforms | Permalink | Comments (0)
Monday, January 13, 2020
As detailed on this US House committee webpage, the "Subcommittee on Health of the Committee on Energy and Commerce will hold a legislative hearing on Wednesday, January 15, 2020, at 10 a.m. in the John D. Dingell Room, 2123 of the Rayburn House Office Building. The hearing is entitled, 'Cannabis Policies for the New Decade'." Interestingly, the hearing page provides a list and links to six House bills with varying approaches to marijuana reform as well as the names and titled of the three government officials now scheduled to testify:
H.R. 171, the "Legitimate Use of Medicinal Marihuana Act" or the "LUMMA"
H.R. 601, the "Medical Cannabis Research Act of 2019"
H.R. 1151, the "Veterans Medical Marijuana Safe Harbor Act"
H.R. 2843, the "Marijuana Freedom and Opportunity Act"
H.R. 3797, the "Medical Marijuana Research Act of 2019"
H.R. 3884, the "Marijuana Opportunity Reinvestment and Expungement Act of 2019" or the "MORE Act of 2019"
Matthew J. Strait
Senior Policy Advisor, Diversion Control Division
Drug Enforcement Administration
Douglas Throckmorton, M.D.
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research
Food and Drug Administration
Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse
National Institutes of Health
Also listed on the website is a "Key Document" in the form of a "Memorandum from Chairman Pallone to the Subcommittee on Health." This memo runs six pages and provides a nice primer on the basics of federal cannabis law as well as a very brief accounting of the six bills listed above.
January 13, 2020 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Friday, January 10, 2020
The question in the title of this post is promoted by this CNN Business piece which asserts in its headline "2020 could be a defining year for the cannabis industry." I find myself a bit skeptical because it seems someone says every January that this year is going to be a defining one for marijuana reform. But I do think there are reasons to see 2020 as an especially big year in this space, and here is part of the article:
2019 was a momentous year for the cannabis industry: Hemp-derived CBD had a heyday, Illinois made history, California got sticky, vapes were flung into flux, and North American cannabis companies received some harsh wake-up calls.
2020 is gearing up to be an even more critical year. There's a well-worn saying in the cannabis business that the emerging industry is so fast-moving that it lives in dog years. 2020 is barely a week old, and cannabis is already making headlines after Illinois kicked off the new year with recreational sales. Other states are inching closer to legalization this year -- with several mulling how best to ensure social equity. Also in 2020, there's the FDA could chill the CBD craze, and a move from Congress could change the game entirely....
Illinois will remain in focus, after it made history last year with the first legislatively-enacted recreational cannabis program. Critical aspects of its program include social equity and social justice measures created to help people and communities most harmed by the War on Drugs. "Underserved groups are holding the industry accountable," said Gia Morón, president for Women Grow, a company founded to further the presence of women in the cannabis industry. "And our legislators are recognizing that [social, gender and minority concerns] are a part of this now."
New York and New Jersey have been flirting with legalization but have held off to navigate some logistics related to aspects that include social equity. The governors of New York, New Jersey, Connecticut and Pennsylvania convened this past fall for a summit on coordinating cannabis and vaping policies. New Jersey is putting a recreational cannabis measure before voters in November, and Gov. Andrew Cuomo vowed Wednesday that New York would legalize cannabis this year....
CBD products have been all the rage, but they may be on shaky ground. CBD oils, creams, foods and beverages have seen an explosion in availability following the passage of the 2018 Farm Bill, which legalized hemp but left plenty of discretion to the US Food and Drug Administration, which regulates pharmaceutical drugs, most food items, additives and dietary supplements.
The FDA is reviewing CBD and has yet to issue formal guidance, although the agency has issued warning letters to CBD makers that make unsubstantiated health claims. Class action lawsuits have been filed against several CBD companies, including two of the largest, Charlotte's Web and CV Sciences, alleging they engaged in misleading or deceptive marketing practices, Stat News reported.
Cannabis insiders are closely awaiting the fate of industry-friendly bills such as the STATES Act, which would recognize cannabis programs at the state level, and the SAFE Banking Act, which would allow for banks to more easily serve cannabis companies. Those and other bills likely won't pass in full...
In addition to the promise of new markets, the evolution of established cannabis programs could also play a significant role in the cannabis business landscape. In California, the world's largest cannabis industry has developed in fits and starts. Regulators are taking aim at an entrenched illicit market as businesses decry tax increases and local control measures that limit distribution....
Canada's "Cannabis 2.0" roll-out of derivative products -- such as edibles, vapes and beverages -- is in its beginning stages. The Canadian publicly traded licensed producers that have been beset by missed and slow market development have bet heavily on these new product forms....
The capital constraints are expected to continue into the first leg of 2020 as some initial bets don't pan out for some companies, said Andrew Freedman, Colorado's former cannabis czar who now runs Freedman & Koski, a firm that consults with municipalities and states navigating legalization. Some companies' low points could create opportunities for other firms and investors that waited out the first cycle, Freedman said. "In 2020, I see that everybody will understand the economics of cannabis a little bit better," he said.
I am with Andrew Freedman in thinking that the realities of marijuana reform and the industry will, at best, become just "a little bit" clearer during 2020. In the end, I think what will matter most is who wins the White House and control of Congress in this big election year. If the status quo holds after the votes are counted, I do not expect to see federal reform anytime soon. But if new leadership takes over the White House or the Senate, then 2021 will become real interesting.
January 10, 2020 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, History of Marijuana Laws in the United States, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Monday, December 30, 2019
Reviewing the year that was 2019 with a round-up of reviews of the year (and decade) in marijuana reform
This holiday season has brought not only the usual "year in review" pieces, but also a number of "decade in review" accountings of big changes since the start of 2010. Interestingly, I have not seen too many "decade in review" pieces focused on marijuana reform developments even though so much has happened in this space since 2010. This new NBC News piece by Zachary Siegel, headlined "Opioids, pot and criminal justice reform helped undermine this decade's War on Drugs," covers some of this ground in a broader context. Here is an excerpt:
If shame was a potent force in fighting against the company that oversold opioids, it was the shedding of stigmas that characterized the massive shift in public opinion toward marijuana in the past decade — which transformed more than that on just about any other policy across the American landscape. In 2000, 63 percent of Americans said the use of marijuana should be illegal, according to polling from Pew Research Center. By 2010, that number had dropped to 52 percent, and for the last 10 years it continued to plunge, shifting the balance in favor of marijuana. In 2019, a full two-thirds of Americans believed cannabis should be legal.
There is no way to characterize this but as a loss for the so-called War on Drugs. Marijuana not only continued to be consumed — with nearly 55 million people who indulge, it’s one of the most widely used drugs — but now, thanks to the legalization drive, there’s a chance to right wrongs of the past. For instance, once legalization goes into effect in Illinois on Jan 1, 2020, the city of Evanston will use tax revenue on cannabis to fund reparations for black residents....
So how did 80-year-old cannabis laws finally begin to crumble this past decade? Though very different in properties and ill effects, marijuana’s image shifted for some of the same reasons that opioids changed the drug conversation in America: White people being criminalized, the medical industry having a role in how to calibrate use of the drug, and a feeling among both liberals and conservatives that filling up jails with users was a waste of lives and money.
Cannabis laws didn’t change all by themselves, and it’s important to recognize the role that grass-roots advocacy played. “The remarkable progress of marijuana legalization over the past decade was driven not by for-profit interests but by people and organizations who care first and foremost about freedom, justice, compassion and human rights,” said Ethan Nadelmann, the founder and former director of the Drug Policy Alliance, the nonprofit that helped get cannabis on the ballot in numerous states.
There is, of course, so much more to say about the past decade in marijuana reform, way too much to say in a single book, let alone a single blog post. Rather than try to cover all that ground, I will be content here to just link to a number of 2019 "year in review" pieces about marijuana reform:
From the National Law Review, "Puff, Puff, Passed: 2019 Marijuana Laws in Review and 2020 Projections"
From MG Magazine, "The Evolving Cannabis Industry: a 2019 Year-End Review"
From The Hill, "2019 was a historic year for marijuana law reform — here's why"
From JD Supra, "The Year in Weed: 2019 Edition"
And from the Dayton Daily News, "Ohio medical marijuana: What happened in the first year"
December 30, 2019 in Campaigns, elections and public officials concerning reforms, History of Marijuana Laws in the United States, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate | Permalink | Comments (0)
Tuesday, December 24, 2019
Alabama Medical Cannabis Study Commission recommends legislation to create medical marijuana program for Yellowhammer State
As reported in this local article, "Friday, the Alabama Medical Cannabis Study Commission voted to recommend legislation that would legalize marijuana for persons with diagnosed medical conditions." Here is more:
The commission voted twelve in favor and three against. Three members abstained. State Health Office Scott Harris voted against the bill.
The proposed bill would allow farmers to grow marijuana, doctors to prescribe marijuana for certain listed conditions, transporters to transport the product, dispensaries to sell the product, and would designate a state testing lab to perform the tests on the product sold on the state.
A new state agency, the Alabama Medical Cannabis agency would regulate cannabis in Alabama. The commission would strictly regulate the product from planting to sell so that all product would be accounted for and limited to grown and produced within the state of Alabama.... The draft did not allow for a smokable products or for edible products such as marijuana gummies and brownies. There is no provision for the legalization of home gardeners to grow marijuana for their own use....
The Commission is chaired by State Senator Tim Melson, R-Florence. Melson is a physician who introduced medical marijuana legislation during the last legislative session. That bill passed the state Senate; but ran into fierce opposition in committee in the Alabama House of Representatives. Senator Melson will introduce this bill, which was recommended by the Commission, in the 2020 Alabama legislative session.
Some marijuana advocates are arguing for a much broader legalization of cannabis in Alabama, including the legalization of recreational marijuana. They have also criticized the ban on edible marijuana products and smokable product as well as the ban on the sell of marijuana plant material. They have also questioned the legality of the ban on importing marijuana products into the state.
During the commission meetings, Melson said that he would join with Senators skeptical of his bill in fighting to defeat any effort to pass recreational marijuana. Some opponents of medical marijuana have told the Alabama Political Reporter that they oppose passage of medical marijuana; because it is an incremental step towards the legalization of recreational marijuana.
Whether or not the state passes a medical marijuana bill will be decided in the Alabama legislature next year.
The full report is available at this link; it is short and reader-friendly.
Friday, December 20, 2019
New Jersey and South Dakota are first two states (of many to come?) with marijuana reform officially on the 2020 ballot
Though we are still 11 months away from Election Day 2020, this past week two state already made official that its voters will have a marijuana reform proposal to consider. Here are the basics via press reports:
New Jersey residents will decide whether to legalize marijuana in the Garden State, after both houses of the state Legislature voted Monday to put the question on the 2020 ballot. The measure passed the state Senate in a 24-16 vote at the Statehouse in Trenton on Monday afternoon, while the state Assembly voted 49-24 with one abstention....
Gov. Phil Murphy made legalizing marijuana for those over 21 one of his campaign promises. In the nearly two years since he took office, the initiative has seen several setbacks. State Senate President Stephen Sweeney announced in late November he would not take the bill to the floor, and would instead seek to put it to the ballot for voters to decide.
From South Dakota: "Medical Marijuana Measure Makes SD Ballot"
Petitions submitted for an initiated measure on legalizing marijuana for medical use have been validated and the measure will appear on South Dakota’s 2020 general election ballot. According to a press release by Secretary of State Steve Barnett, the petitions were officially validated Thursday. It will be titled Initiated Measure 26. An initiated measure currently requires 16,961 valid signatures in order to qualify for the ballot.
My understanding is that there could be as many as a half-dozen additional states, including Arizona, Arkansas, Florida, Nebraska and North Dakota, that could end up having marijuana ballot measures for voters in 2020.
December 20, 2019 in Campaigns, elections and public officials concerning reforms, Initiative reforms in states, Medical Marijuana State Laws and Reforms, Recreational Marijuana State Laws and Reforms | Permalink | Comments (0)
Wednesday, December 11, 2019
Writing in Forbes, Mike Adams has this amusing commentary under the headline ""Federal Marijuana Legalization Is A Lock – But How, When?". Here are excerpts:
Although pro-pot groups insist that 2019 has been the best year ever in the realm of cannabis reform, the reality is not much progress has transpired. It is only revered as the “best year” because even less occurred in the years that came before it. But no matter how you size it up, nothing plus bupkis still equals squat. In spite of everything, marijuana remains illegal across most of the United States.
At the state level, many advocates predicted that New York and New Jersey would be the next to legalize weed. Well, that didn’t happen. In fact, Illinois swooped in and legalized first, making both states look like dorks. But aside from that, no other significant pot laws were passed at the state level in 2019. We also learned that police are still out there arresting more than 600,000 pot offenders nationwide every year — mostly small timers, too.
In addition, some states, like California, are having trouble curbing the black market, and tainted pot products, most of which were initially believed to be counterfeits, are finding their way into legal dispensaries. To make matters worse, the cannabis industry, as a whole, is struggling to keep it together long enough to see profitability. Layoffs are prevalent and some of the nation’s most popular cannabis magazines are at risk of going under. There’s just no possible way that 2019 should be considered a banner year for cannabis.
Federally speaking, parts of Congress dilly-dallied around with the notion of forging some kind of change in the realm of national cannabis reform, but the powers against it are still too strong to penetrate. Rumor has it that the cannabis trade’s legislative pride and joy known as the SAFE Act is presently being gnawed on by rats in the basement of the Senate chamber. Its last words were reportedly, “Y’all know I’m not really a marijuana bill, right?” And the MORE Act, the proposal that got everyone to stop giving two-flying squirts about SAFE, well, that sucker has already been buried out behind the Capitol building alongside last year’s great green hope, the STATES Act. Remember that one? No? Don’t feel bad, no one does. No one cares. The point is that cannabis hopefuls have spent all year yapping about legislation that doesn’t have what it takes to go the distance.
But the stakes are about to change in 2020, which could set the nation up for legal weed the following year. There’s only one catch. Americans – 66 percent of which are on board with legalizing the leaf the same as beer and tobacco – have to vote in the next election. And for the right people.
The first thing all cannabis hopefuls need to come to grips with is that the SAFE Act and the MORE Act are dead. No, that’s not official or anything. There hasn’t been a press release issued saying that Senate Majority Leader Mitch McConnell and his Republican-dominated Senate are refusing to entertain these bills before year’s end. But trust me on this one – SAFE and MORE are finished.
They could, however, be resurrected in 2020. But for either of them to get any further attention, the legislative process would have to start from the very beginning. And unless the Republicans in the Senate have a change of heart in the next few months, the prospect of getting these bills or any others aimed at legalizing weed nationwide isn’t going much further next year than they did in 2019. Remember, as of January, Congress is still playing with the same losing team.
It is the November election when all the magic could happen. It’s a time when the stoner stars could align and contribute to getting America high again. But that all depends on the nation’s political loyalty when it comes time to vote. There are several Senate seats up for grabs. It is conceivable that the Democrats could win these seats and take control over the Senate. If that happens, McConnell, the man presently standing in the way of cannabis reform in the U.S, would be dethroned as Senate Majority Leader. That’s when the cannabis debate could really find its footing in both chambers. Because there would no longer be anyone on the Hill that cares enough to try to stop it. And anyone who did oppose would surely be out voiced by Democratic rule.
Furthermore, a Democratic president (except for Joe Biden) would undoubtedly support most cannabis legislation, and there is even a solid chance that President Trump would sign off on it if he wins a second term. Unless, of course, Trump decides to make a statement by stamping it with a veto just to prevent the Democrats (the same ones trying to have him impeached) from making any progress. Grudges tend to have an extremely long shelf life when it comes to politics.
But here’s the deal. If both Trump and the Democrats find success in the next election, the best-case scenario for getting marijuana legalization done at the federal level in 2021 is for Trump to make it his idea and let the Democrats follow suit.
December 11, 2019 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Wednesday, November 20, 2019
The title of this post is the title of this notable new Washington Post commentary. I am not keen on the headline, but I am keep on the contents, especially because a Democratic Prez Candidate Debate scheduled for tonight makes this piece is a timely must-read. But that is true primarily because it is authored by Keith Humphreys, who I always consider to be a timely must-read. Here are excerpts:
When former vice president Joe Biden asserted over the weekend that marijuana shouldn’t be legal because it might be a “gateway” to hard drug use, pro-legalization critics were quick to paint him as an out-of-touch codger still fighting the last drug war. But the reaction isn’t entirely fair: Yes, the marijuana gateway theory that was omnipresent in the 1980s was at best distorted and at worst dishonest. Nevertheless, gateways between marijuana and other addictive substances are real — and they swing in both directions.
During the heyday of anti-marijuana sentiment in America, fear-based prevention programs warned adolescents that a huge percentage of adults who experienced some horrible drug-related outcome (e.g., becoming addicted to heroin) had used marijuana when they were younger. These statistics were technically accurate, but even as teenagers, most of my classmates and I could see the logical flaws in the implication that marijuana was inevitably a road to ruin. Just because most people who used heroin had previously used marijuana didn’t prove that most people who used marijuana would go on to use heroin.
But strip away that era’s ideological agenda, designed to assign marijuana a unique and powerful role in ruining lives, and a more nuanced underlying truth about gateways reveals itself. People who become users of almost any addictive substance are at higher risk of subsequently using and having problems with other substances. A recent National Academies of Sciences, Engineering, and Medicine report found moderate evidence that this is the case for cannabis, but it’s also true of other drugs, including legal ones such as alcohol and tobacco. At least three causal forces can create such gateways.
First, people can become habituated to particular routes of administering drugs....
Social networks are the second force behind drug gateways. Drug use, like many other behaviors, is very commonly a social activity. This creates gateway effects between drugs in part because classes of behavior (e.g., playing sports, traveling to exotic locales, collecting antiques or, yes, taking drugs) come to seem more normal when your friends all engage in them....
Gateways can also result from users’ desire to combine the effect of a new drug with a familiar one. Established cocaine users sometimes become heavy drinkers (and vice versa) because they find the cocaethylene produced in the body by this drug combination particularly euphoric. Similarly, the fact that many people take the trouble to carve out cigars and fill them with marijuana (known as smoking “blunts”) demonstrates that tobacco and marijuana combined is uniquely reinforcing to some users.
So those who mocked Biden’s claim that marijuana could be a gateway to other drugs thus got the science wrong. There are plenty of ways using the drug can make people more likely to use other substances.
But research also shows that singling out marijuana is wrong; the gateway effect is in fact shared by many substances. If Biden continues to oppose the legalization of marijuana on the grounds that marijuana could lead to other drugs, it is only fair that he should answer another question: Why have we made alcohol and tobacco legal and often subjected them to insufficient restrictions when they are powerful gateways, too?
November 20, 2019 in Campaigns, elections and public officials concerning reforms, Medical community perspectives | Permalink | Comments (0)
US House Judiciary Committee advances sweeping marijuana reform bill, the MORE Act, by a vote of 24-10
As report in this press piece, headlined "House panel passes bill aiming to legalize marijuana, but top Democrat concedes ‘Senate will take its own time,’" a notable marijuana reform bill advanced in Congress today, but its long-term prospects are still limited. Here are the basics:
The Democratic-controlled House Judiciary Committee on Wednesday voted in favor a bill that decriminalizes marijuana at the federal level, with a couple of Republicans supporting the measure.
The panel’s chairman, however, had acknowledged Tuesday that the Marijuana Opportunity Reinvestment and Expungement (MORE) Act could be a tough sell in the Republican-controlled Senate. “The Senate will take its own time, but then the Senate always does,” said Jerry Nadler, the New York Democrat. He aimed to sound upbeat during Tuesday’s news conference ahead of Wednesday’s markup session for the bill: “The energy and the political pressure from the various states is growing rapidly. The Senate is subject to that, too. We’ll accomplish this.”...
Nadler, for his part, had on Tuesday described the committee vote on the MORE Act as “part of a long-term fight.” He stressed Wednesday that House lawmakers can negotiate with the Senate. Pro-marijuana activists have been celebrating the action in the House Judiciary Committee, with the National Organization for the Reform of Marijuana Laws, also known as NORML, calling it the “biggest marijuana news of the year” and the “first-ever vote to remove marijuana from the Controlled Substances Act.”
Besides decriminalizing marijuana at the federal level, the MORE Act aims to expunge prior marijuana convictions and spur re-sentencing hearings for people still under supervision. It also would set up a 5% sales tax on marijuana products that would fund three grant programs, including one that would provide job training, legal aid and other services to the individuals hit hardest by the War on Drugs....
The MORE Act [available here] has more than 50 co-sponsors in the House, including Republican Rep. Matt Gaetz of Florida, a member of the House Judiciary Committee who voted for the measure on Wednesday. The backers of the bill in the Senate include Democratic presidential hopefuls Sen. Kamala Harris of California, Sen. Cory Booker of New Jersey and Sen. Elizabeth Warren of Massachusetts.
The House committee voted 24-10 in favor of the bill on Wednesday, a House clerk said. Georgia Rep. Doug Collins, the committee’s top Republican, was among the GOP lawmakers who didn’t support the measure.
Collins said the MORE Act was a non-starter for most of his Republican colleagues. He suggested it won’t become law and lead to real change. “Do we want to accomplish something or do we just want to make a political statement?” Collins asked.
Groups in Washington that have disclosed lobbying on the MORE Act this year include the National Association of Mutual Insurance Companies (NAMIC), the Cannabis Trade Federation, the National Association of Criminal Defense Lawyers, the American Civil Liberties Union and NORML.
The cannabis industry has set a fresh record for its overall annual lobbying spending in Washington, with an outlay of $3.77 million through this year’s third quarter as it has pushed for a bill that would protect financial institutions that work with the marijuana industry.